REDUCTION OF ENDOTOXIN IN POLYSIALIC ACIDS
    11.
    发明授权
    REDUCTION OF ENDOTOXIN IN POLYSIALIC ACIDS 有权
    在多聚异径内毒素

    公开(公告)号:EP2115010B1

    公开(公告)日:2011-10-19

    申请号:EP08709658.2

    申请日:2008-02-28

    IPC分类号: C08B37/00

    摘要: The present invention relates to process for reducing the endotoxin content of a sample of fermentation broth containing polysialic acid and endotoxin comprising the sequential steps: (i) adding to the sample a base having a pKa of at least 12 to form a basic solution having a pH of at least 12, incubating the solution for a pre - determined time at a pre - determined temperature; and (ii) recovery of PSA, suitably by (iii) passing the sample through an anion - exchange column whereby polysialic acid is absorbed on the ion exchange resin; (iv) washing the column with one washing buffer, whereby polysialic acid remains absorbed on the ion exchange resin; and (v) eluting the polysialic acid from the column using an elution buffer to provide a product solution of polysialic acid having reduced endoto xin content.

    REDUCTION OF ENDOTOXIN IN POLYSIALIC ACIDS
    15.
    发明公开
    REDUCTION OF ENDOTOXIN IN POLYSIALIC ACIDS 有权
    在多聚异径内毒素

    公开(公告)号:EP2115010A1

    公开(公告)日:2009-11-11

    申请号:EP08709658.2

    申请日:2008-02-28

    IPC分类号: C08B37/00

    摘要: The present invention relates to process for reducing the endotoxin content of a sample of fermentation broth containing polysialic acid and endotoxin comprising the sequential steps: (i) adding to the sample a base having a pKa of at least 12 to form a basic solution having a pH of at least 12, incubating the solution for a pre - determined time at a pre - determined temperature; and (ii) recovery of PSA, suitably by (iii) passing the sample through an anion - exchange column whereby polysialic acid is absorbed on the ion exchange resin; (iv) washing the column with one washing buffer, whereby polysialic acid remains absorbed on the ion exchange resin; and (v) eluting the polysialic acid from the column using an elution buffer to provide a product solution of polysialic acid having reduced endoto xin content.

    VACCINES FOR ORAL USE WHICH CONTAIN LIPOSOME-ENTRAPPED DNA
    18.
    发明授权
    VACCINES FOR ORAL USE WHICH CONTAIN LIPOSOME-ENTRAPPED DNA 有权
    疫苗口服的脂质体和核酸CONTAIN

    公开(公告)号:EP1217989B1

    公开(公告)日:2005-12-14

    申请号:EP00964471.7

    申请日:2000-10-02

    IPC分类号: A61K9/127 A61K48/00 C12N15/88

    CPC分类号: A61K9/1272

    摘要: An oral vaccine contain liposomes and complexed or, preferably entrapped, DNA operatively encoding an antigen in which the liposomes are formed from components including cationic compounds and zwitterionic phospholipids. The hydrophobic groups within the liposome forming components must include at least one group which is saturated. This is believed to raise the transition temperature, rendering the liposomes more stable when delivered orally. The compositions have been found to give detectable increased in IgA levels, secreted immunoglobulins of importance in efficacious oral vaccine delivery.